Cargando…

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance

Mostrar otras versiones (1)

HORMA domain-containing protein 1 (HORMAD1), is normally expressed only in the germline, but is frequently re-activated in human triple-negative breast cancer (TNBC); however, its function in TNBC is largely unknown. In the present study, the expression and biological significance of HORMAD1 in huma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zong, Beige, Sun, Lu, Peng, Yang, Wang, Yihua, Yu, Yu, Lei, Jinwei, Zhang, Yingzi, Guo, Shipeng, Li, Kang, Liu, Shengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165579/ https://www.ncbi.nlm.nih.gov/pubmed/34036395 http://dx.doi.org/10.3892/or.2021.8089

Ejemplares similares

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells
por: Zhang, Yingzi, et al.
Publicado: (2021)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
por: Wang, Yihua, et al.
Publicado: (2021)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer
por: Guo, Shipeng, et al.
Publicado: (2019)

Mouse HORMAD1 and HORMAD2, Two Conserved Meiotic Chromosomal Proteins, Are Depleted from Synapsed Chromosome Axes with the Help of TRIP13 AAA-ATPase
por: Wojtasz, Lukasz, et al.
Publicado: (2009)

Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance
por: Tarantino, Dalia, et al.
Publicado: (2022)

The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells
por: Gao, Yanzhe, et al.
Publicado: (2018)

Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8–MCM9 complex and compromises DNA mismatch repair in cancer cells
por: Liu, Kang, et al.
Publicado: (2020)

HORMAD2 methylation‐mediated epigenetic regulation of gene expression in thyroid cancer
por: Lin, Qiuyu, et al.
Publicado: (2018)

Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Qu, Fanli, et al.
Publicado: (2020)

Although c-MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER-positive breast cancer
por: Chen, Rui, et al.
Publicado: (2020)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity
por: Wang, Xian, et al.
Publicado: (2018)

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021)

Hormad1 Mutation Disrupts Synaptonemal Complex Formation, Recombination, and Chromosome Segregation in Mammalian Meiosis
por: Shin, Yong-Hyun, et al.
Publicado: (2010)

Ectopically Expressed Meiosis-Specific Cancer Testis Antigen HORMAD1 Promotes Genomic Instability in Squamous Cell Carcinomas
por: Gantchev, Jennifer, et al.
Publicado: (2023)

Correction: Hormad1 Mutation Disrupts Synaptonemal Complex Formation, Recombination, and Chromosome Segregation in Mammalian Meiosis
por: Shin, Yong-Hyun, et al.
Publicado: (2011)

KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells
por: Jiang, Meng, et al.
Publicado: (2017)

ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line
por: Hwang, Eunjoo, et al.
Publicado: (2018)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Meiotic cohesins mediate initial loading of HORMAD1 to the chromosomes and coordinate SC formation during meiotic prophase
por: Fujiwara, Yasuhiro, et al.
Publicado: (2020)

The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks
por: Herrera, Luis Reza, et al.
Publicado: (2023)

MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
por: Mehlich, Dawid, et al.
Publicado: (2021)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2017)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study
por: Passos, Ioannis D, et al.
Publicado: (2023)

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022)

The cancer/testis antigen HORMAD1 mediates epithelial–mesenchymal transition to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway in lung cancer
por: Liu, Kang, et al.
Publicado: (2022)

Multi-color dSTORM microscopy in Hormad1(-/)(-) spermatocytes reveals alterations in meiotic recombination intermediates and synaptonemal complex structure
por: Koornneef, Lieke, et al.
Publicado: (2022)

Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
por: Chen, Rujing, et al.
Publicado: (2021)

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

Corema album Leaves Mediate DNA Damage in Triple-Negative Breast Cancer Cells
por: Cerquido, Ana Sofia, et al.
Publicado: (2022)

Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
por: Chen, Rui, et al.
Publicado: (2018)

Curcuma zedoaria petroleum ether extract reverses the resistance of triple-negative breast cancer to docetaxel via pregnane X receptor
por: Qiao, En-Qi, et al.
Publicado: (2021)

Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers
por: Domagala, Pawel, et al.
Publicado: (2015)

The conserved AAA ATPase PCH-2 distributes its regulation of meiotic prophase events through multiple meiotic HORMADs in C. elegans
por: Russo, Anna E., et al.
Publicado: (2023)

A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer
por: Abdelmaksoud, Bader A, et al.
Publicado: (2020)

TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer
por: Demeule, Michel, et al.
Publicado: (2021)

Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer
por: Lee, Kevin J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_56etpnqsmn7nf2k3dsgvovjfhf